Checkpoint therapeutics inc

Major-Pharmaceuticals

CKPT


2 Gansevoort Street
New York , NY 10014

Executive/
Director

Price

  • Last Close
  • $ 3.64
    $ +0.36 10.98 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.32 - $1.39
  • YTD
  • 14.5%

  • Trading Volume
  • 66,758
  • Market Cap Full
  • $ 42.8M
  • Shares Outstanding
  • 11.7M
    Mar 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - 56.3% 13.1% 57.1% -5% 21% -43.6% -56% -9.6% 14.5%
Q2 - -20.4% -25.9% 8.7% 4% -6.1% -41.3% 9.8% 2% -
Q3 - -17.6% 19.7% -19.4% 8% 11.9% 1% -31.2% -2.1% -
Q4 60% -51.5% -43.1% -30.2% 1.2% -5.8% 391.4% 42.2% -20.1% -
J F M A M J J A S O N D
2025 14.5% - - - - - - - - - - -
2024 -10.9% 2.5% -1% -29.5% 30.8% 7.9% 16.5% -2.1% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%-52%-53%-4%49%20%64%-55%39%14%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.35 -0.18 -0.06 -0.09 -2 -0.89
Q2 - 0.28 -0.23 -0.15 -0.09 -0.12 -1.6 -1.05
Q3 - - -0.32 -0.15 -0.09 -0.14 -1.2 -0.29
Q4 - 0.26 -0.37 -0.22 -0.17 -3.95 -2.29 -
A 0 0.5 -1.3 -0.7 -0.41 -7.5 -7.1 -2.23

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 70.3 8.5 11.7
Jun - 75.5 87.5 -
Sep 56.4 78.5 88.6 -
Dec - 7.6 8.8 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - 0.1 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -11.6 - - - 37
Equity multiplier - - - - -